New-onset diabetes and cardiovascular events in essential hypertensives: A 6-year follow-up study

International Journal of Cardiology

Volumn 153, Issue 2, 2011, Pages 154-158

  Tsiachris, Dimitris ^a   Tsioufis, Costas ^a   Thomopoulos, Costas ^a   Syrseloudis, Dimitris ^a   Antonakis, Velissarios ^a   Lioni, Louiza ^a   Kallikazaros, Ioannis ^a   Makris, Thomas ^a   Papademetriou, Vasilis ^b   Stefanadis, Christodoulos I ^a  

^a UNIVERSITY OF ATHENS   (Greece)

^b GEORGETOWN UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Coronary artery disease; Diabetes; Epidemiology; Hypertension

Indexed keywords

ADULT; AGE; ARTICLE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CLINICAL EVALUATION; COHORT ANALYSIS; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DIABETES MELLITUS; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE DURATION; DISEASE SEVERITY; ESSENTIAL HYPERTENSION; FAMILY HISTORY; FEMALE; FOLLOW UP; HUMAN; INCIDENCE; INDEPENDENT VARIABLE; MAJOR CLINICAL STUDY; MALE; NEW ONSET DIABETES MELLITUS; PREDICTOR VARIABLE; PRIORITY JOURNAL; RECURRENT DISEASE; STROKE; SYSTOLIC BLOOD PRESSURE; WAIST CIRCUMFERENCE;

AGE OF ONSET; CARDIOVASCULAR DISEASES; DIABETES MELLITUS; FEMALE; FOLLOW-UP STUDIES; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; RISK FACTORS;

EID: 81755171422     PISSN: 01675273     EISSN: 18741754     Source Type: Journal    
DOI: 10.1016/j.ijcard.2010.08.041     Document Type: Article

References (29)

1. R.M. Conroy, K. Pyörälä, and A.P. Fitzgerald Estimation of ten-year risk of fatal cardiovascular disease in Europe: the SCORE project Eur Heart J 24 2003 987 1003
2. M.H. Alderman, H. Cohen, and S. Madhavan Diabetes and cardiovascular events in hypertensive patients Hypertension 33 1999 1130 1134
3. P. Verdecchia, F. Angeli, and G. Reboldi New-onset diabetes, antihypertensive treatment, and outcome Hypertension 50 2007 459 460
4. L.H. Lindholm, M. Persson, P. Alaupovic, B. Carlberg, A. Svensson, and O. Samuelsson Metabolic outcome during 1 year in newly detected hypertensives: results of the Antihypertensive Treatment and Lipid Profile in a North of Sweden Efficacy Evaluation (ALPINE study) J Hypertens 21 2003 1563 1574
5. J.I. Barzilay, B.R. Davis, and J.A. Cutler Fasting glucose levels and incident diabetes mellitus in older nondiabetic adults randomized to receive 3 different classes of antihypertensive treatment. A report from the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT) Arch Intern Med 166 2006 2191 2201
6. L. Hansson, L.H. Lindholm, and L. Niskanen Effect of angiotensin- converting-enzyme inhibition compared with conventional therapy on cardiovascular morbidity and mortality in hypertension: the Captopril Prevention Project (CAPPP) randomised trial Lancet 353 1999 611 616
7. L.H. Lindholm, H. Ibsen, and K. Borch-Johnsen Risk of new-onset diabetes in the Losartan Intervention For Endpoint reduction in hypertension study J Hypertens 20 2002 1879 1886
8. L. Hansson, T. Hedner, and P. Lund-Johansen Randomised trial of effects of calcium antagonists compared with diuretics and beta-blockers on cardiovascular morbidity and mortality in hypertension: the Nordic Diltiazem (NORDIL) study Lancet 356 2000 359 365
9. L.E. Eberly, J.D. Cohen, R. Prineas, and L. Yang Intervention Trial Research group: impact of incident diabetes and incident nonfatal cardiovascular disease on 18-year mortality: the multiple risk factor intervention trial experience Diab Care 26 2003 848 854
10. N.L. Smith, N.L. Smith, and J.I. Barzilay New-onset diabetes and risk of all-cause and cardiovascular mortality: the Cardiovascular Health Study Diab Care 29 2006 2012 2017
11. M. Moser Is new-onset diabetes of clinical significance in treated hypertensive patients? J Clin Hypertens 8 2006 126 132
12. P. Verdecchia, G. Reboldi, and F. Angeli Adverse prognostic significance of new diabetes in treated hypertensive subjects Hypertension 43 2004 963 969
13. T.A. Aksnes, S.E. Kjeldsen, M. Rostrup, P. Omvik, T.A. Hua, and S. Julius Impact of new-onset diabetes mellitus on cardiac outcomes in the Valsartan Antihypertensive Long-term Use Evaluation (VALUE) trial population Hypertension 50 2007 467 473
14. J. Kostis, A. Wilson, R. Freudenberger, N. Consgrove, S. Pressel, and B. Davis Long term effect of diuretic based therapy on fatal outcomes in subjects with isolated systolic hypertension with and without diabetes Am J Cardiol 95 2005 29 35
15. G. Mancia, G. De Backer, and A. Dominiczak Management of arterial hypertension of the European Society of Hypertension; European Society of Cardiology. 2007 Guidelines for the management of arterial hypertension: the task force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC) J Hypertens 25 2007 1105 1187
16. American Diabetes Association Clinical practice recommendations 2000 Diab Care 23 Suppl. 1 2001 S1 S116
17. Expert panel on detection, evaluation, and treatment of high school blood cholesterol on adults: executive summary of the third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III) JAMA 285 2001 2486
18. R.B. Devereux, D.R. Alonso, and E.M. Lutas Echocardiographic assessment of left ventricular hypertrophy: comparison to necropsy findings Am J Cardiol 57 1986 450-8
19. R.V. Luepker, F.S. Apple, and R.H. Christenson Case definitions for acute coronary heart disease in epidemiology and clinical research studies: a statement from the AHA Council on Epidemiology and Prevention; AHA Statistics Committee; World Heart Federation Council on Epidemiology and Prevention; the European Society of Cardiology Working Group on Epidemiology and Prevention; Centers for Disease Control and Prevention; and the National Heart, Lung, and Blood Institute Circulation 108 2003 2543 2549
20. R. Izzo, G. De Simone, and M. Chinali Insufficient control of blood pressure and incident diabetes Diab Care 32 2009 845 850
21. T. Gress, J. Nieto, E. Shahar, M. Wofford, and F. Brancati Hypertension and antihypertensive therapy as risk factors for type 2 diabetes mellitus N Engl J Med 342 2000 905 912
22. S. Bangalore, S. Parkar, E. Grossman, and F. Messerli A meta-analysis of 94,492 patients with hypertension treated with beta blockers to determine the risk of new-onset diabetes mellitus Am J Cardiol 100 2007 1254 1262
23. W.J. Elliot, and P. Meyer Incident diabetes in clinical trials of antihypertensive drugs: a network meta-analysis Lancet 369 2007 201 207
24. A. Gupta, B. Dahlof, J. Dobson, P. Sever, H. Wedel, and N.R. Poulter Determinants of new-onset diabetes among 19,257 hypertensive patients randomized in the Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pressure Lowering Arm and the relative influence of antihypertensive medication Diab Care 31 2008 982 988
25. T. Almgren, L. Wilhelmsen, O. Samuelsson, A. Himmelmann, A. Rosengren, and O. Andersson Diabetes in treated hypertension is common and carries a high cardiovascular risk: results from a 28-year follow-up J Hypertens 25 2007 1311 1317
26. K. Dunder, L. Lind, B. Zethelius, L. Berglund, and H. Lithell Increase in blood glucose concentration during antihypertensive treatment as a predictor of myocardial infarction: population based cohort study BMJ 326 2003 681 684
27. C. Tsioufis, E. Vezali, and D. Tsiachris Left ventricular hypertrophy versus chronic kidney disease as predictors of cardiovascular events in hypertension: a Greek 6-year-follow-up study J Hypertens 27 4 2009 744 752
28. J. Redon, R. Cifkova, and S. Laurent Mechanisms of hypertension in the cardiometabolic syndrome J Hypertens 27 2009 441 451
29. A.J. Coats Ethical authorship and publishing Int J Cardiol 131 2009 149 150